| First Author | Nakajima K | Year | 2013 |
| Journal | J Invest Dermatol | Volume | 133 |
| Issue | 11 | Pages | 2555-2565 |
| PubMed ID | 23633022 | Mgi Jnum | J:202388 |
| Mgi Id | MGI:5518973 | Doi | 10.1038/jid.2013.199 |
| Citation | Nakajima K, et al. (2013) Barrier abnormality due to ceramide deficiency leads to psoriasiform inflammation in a mouse model. J Invest Dermatol 133(11):2555-65 |
| abstractText | It has been recognized that ceramides are decreased in the epidermis of patients with psoriasis and atopic dermatitis. Here, we generated Sptlc2 (serine palmitoyltransferase long-chain base subunit 2)-targeted mice (SPT-cKO mice), thereby knocking out serine palmitoyltransferase (SPT), the critical enzyme for ceramide biosynthesis, in keratinocytes. SPT-cKO mice showed decreased ceramide levels in the epidermis, which impaired water-holding capacity and barrier function. From 2 weeks of age, they developed skin lesions with histological aberrations including hyperkeratosis, acanthosis, loss of the granular layer, and inflammatory cell infiltrates. Epidermal Langerhans cells showed persistent activation and enhanced migration to lymph nodes. Skin lesions showed upregulation of psoriasis-associated genes, such as IL-17A, IL-17F, IL-22, S100A8, S100A9, and beta-defensins. In the skin lesions and draining lymph nodes, there were increased numbers of gammadelta T cells that produced IL-17 (gammadelta-17 cells), most of which also produced IL-22, as do Th17 cells. Furthermore, IL-23-producing CD11c(+) cells were observed in the lesions. In vivo treatment of SPT-cKO mice with an anti-IL-12/23p40 antibody ameliorated the skin lesions and reduced the numbers of gammadelta-17 cells. Therefore, we conclude that a ceramide deficiency in the epidermis leads to psoriasis-like lesions in mice, probably mediated by IL-23-dependent IL-22-producing gammadelta-17 cells. |
